Here are today's top Wall Street analyst ratings where finbox.io's unbiased fair value estimates support the recommendation.
Top Upgrades and Buy Ratings
Deutsche Bank, Oppenheimer and Sanford C. Bernstein reiterated Teva Pharmaceutical (NYSE:TEVA) at Buy/Outperform. Shares look to be trading at a significant discount to fair value.
Needham & Company reiterated BroadSoft (Nasdaq:BSFT) at Buy. Finbox.io's fair value estimate implies that shares are 18% undervalued.
Seaport Global Securities initiated coverage on Beacon Roofing Supply (Nasdaq:BECN) with a Buy rating and set a $53 price target. Nine valuation models imply a similar fair value of $54 per share representing 17% upside.
Citigroup started coverage on Micron Technology (Nasdaq:MU) with a Buy rating. Shares jumped over 6% on the news. The stock still has almost 15% margin of safety.
Stephens downgraded Core Laboratories (NYSE:CLB) from Equal Weight to Underweight. Shares are currently trading at a large premium.
RBC Capital Markets downgraded IDEX Corp. (NYSE:IEX) from Outperform to Sector Perform. Eleven valuation models imply the stock is 27% overvalued.
Morgan Stanley lowered its price target for Illumina (Nasdaq:ILMN) to $100 per share. Fundamentals support the lower price target.
Bank of America downgraded AptarGroup (NYSE:ATR) from Buy to Underperform. Nine valuation models conclude that the company currently has a negative 22% margin of safety.